EUVIMEDEUVIMED entdecken
Crossref

Clinical trends in Catalonia’s Primary Care Setting (2018–2023) in Elderly (≥75 years) and Frail Adults with Type 2 Diabetes

Maria Ramon-Granés, Berta Fernàndez-Camins, Carolina Lapena-Estella, Francesc Orfila-Pernas, Joan Barrot-de la Puente, Bogdan Vlacho, Dídac Mauricio, Elena Navas-Méndez, Josep Franch-Nadal

Primary Care Diabetes · 2026-06 · 20 (3) · 306-312

DOI: 10.1016/j.pcd.2026.03.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Primary Care Diabetes, 2026-06. Verfasst von Maria Ramon-Granés und 8 weiteren Autor:innen. Beteiligte Einrichtung: DAP-Cat group. Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Primary Health Care, Frail Elderly, Hypoglycemic Agents. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Non-US Government Research Support type, Generalitat de Catalunya.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM To describe temporal changes in sociodemographic and clinical characteristics, glycaemic control, and pharmacological treatment among older or frail adults with type 2 diabetes (T2D) in Catalonia between 2018 and 2023. METHODS Two cross-sectional analyses (30 June 2018 and 30 June 2023) were conducted using the SIDIAP primary care database, covering 75-80% of the Catalan population. Adults with T2D were included. Frailty was defined using the eFRAGICAP index. Comparisons were performed in individuals aged ≥ 75 years, and those classified as severely frail. RESULTS Individuals aged ≥ 75 years with T2D raised from 195,883 to 250,571, while those with severe frailty from 10,966 to 32,665. Mean age was approximately 84 years, over 60% were women, and most lived in socioeconomically deprived areas. Mean HbA1c remained stable (6.80-6.87%), around 65% achieving HbA1c < 7%. Metformin remained the most prescribed drug. Use of sulfonylurea and insulin declined, whereas DPP-4i, SGLT2i and GLP-1RA increased, especially among frail individuals. All-cause mortality declined, most markedly in the frail group (25.2% vs 6.9%, p < 0.001). CONCLUSIONS Despite population ageing and increasing frailty, glycaemic control remained stable and all-cause mortality declined, supporting individualised, holistic diabetes care in older and frail adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Primary Health CareFrail ElderlyHypoglycemic AgentsFrailtyGlycemic ControlPractice Patterns, Physicians'HumansFemaleAgedCross-Sectional StudiesAged, 80 and overSpainMaleBlood GlucoseAge FactorsGlycated HemoglobinRisk FactorsTime Factors

Stichwörter der Autor:innen

FrailtyMortalityOlder adultsPharmacological treatmentType 2 diabetes

Substanzen

Hypoglycemic AgentsBlood GlucoseGlycated Hemoglobin

Autor:innen und Institutionen

  • DAP-Cat group. Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain; Hospital at Home Service, Hospital de Figueres, Fund…
  • DAP-Cat group. Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain; Department of Endocrinology & Nutrition, Hospital de…
  • DAP-Cat group. Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain; Primary Health Care Center Sanllehy, Gerència d'Àmbi…
  • Unitat de Suport a la Recerca Barcelona, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain.
  • DAP-Cat group. Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain; Primary Health Care Center Salt, Gerència d'Àmbit d'…
  • DAP-Cat group. Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain; Centro de Investigación Biomédica en Red de Diabetes…

Förderung

  • Non-US Government Research Support type
  • Generalitat de Catalunya

Zitieren

APA

Ramon-Granés, M., Fernàndez-Camins, B., Lapena-Estella, C., Orfila-Pernas, F., la Puente, J. B., Vlacho, B., Mauricio, D., Navas-Méndez, E., & Franch-Nadal, J. (2026). Clinical trends in Catalonia’s Primary Care Setting (2018–2023) in Elderly (≥75 years) and Frail Adults with Type 2 Diabetes. Primary Care Diabetes, 20(3), 306-312. https://doi.org/10.1016/j.pcd.2026.03.010

Vancouver

Ramon-Granés M, Fernàndez-Camins B, Lapena-Estella C, Orfila-Pernas F, la Puente JB, Vlacho B, et al. Clinical trends in Catalonia’s Primary Care Setting (2018–2023) in Elderly (≥75 years) and Frail Adults with Type 2 Diabetes. Primary Care Diabetes. 2026;20(3):306-312. doi:10.1016/j.pcd.2026.03.010

BibTeX
@article{RamonGrans2026,
  author = {Ramon-Granés, Maria and Fernàndez-Camins, Berta and Lapena-Estella, Carolina and Orfila-Pernas, Francesc and la Puente, Joan Barrot-de and Vlacho, Bogdan and Mauricio, Dídac and Navas-Méndez, Elena and Franch-Nadal, Josep},
  title = {Clinical trends in Catalonia’s Primary Care Setting (2018–2023) in Elderly (≥75 years) and Frail Adults with Type 2 Diabetes},
  journal = {Primary Care Diabetes},
  year = {2026},
  volume = {20},
  number = {3},
  pages = {306--312},
  doi = {10.1016/j.pcd.2026.03.010}
}
Kostenlos starten →